A Study to Evaluate Efficacy and Safety of SAR441566 in Adults With Plaque Psoriasis
NCT06073119
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
221
Enrollment
INDUSTRY
Sponsor class
Conditions
Psoriasis
Interventions
DRUG:
SAR441566
DRUG:
Placebo
Sponsor
Sanofi